Stress hyperglycemia: Etiopathogenesis, prevalence and importance

Hyperglycemia: Causes, Symptoms and Treatment Options

Volumn , Issue , 2012, Pages 1-38

  Koracevic, Goran ^a  

^a UNIVERSITY OF NI   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892999469     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. Corathers SD, Falciglia M. The role of hyperglycemia in acute illness: supporting evidence and its limitations. Nutrition 2011;27:276-81.
2. Usami M, Sakata Y, Nakatani D, Shimizu M, Suna S, Matsumoto S, Hori M, Sato H; Osaka Acute Coronary Insufficiency Study (OACIS) Group. Effect of intracoronary thrombectomy on 30-day mortality in non-diabetic patients with acute hyperglycemia after acute myocardial infarction. J Cardiol 2009;53:429-36.
3. Gornik I, Vujaklija A, Lukić E, Madzarac G, Gasparović V. Hyperglycemia in sepsis is a risk factor for development of type II diabetes. J Crit Care 2010;25:263-9.
4. Bernard C. Lecons de physiologie experimentale appliqué a la medicine. Balliere, Paris 1;1855:296-313.
5. Krenitsky J. Glucose control in the intensive care unit: a nutrition support perspective. Nutr Clin Pract 2011;26:31-43.
6. Tiruvoipati R, Chiezey B, Lewis D, Ong K, Villanueva E, Haji K, Botha J. Stress hyperglycemia may not be harmful in critically ill patients with sepsis. J Crit Care 2011 [Epub ahead of print].
7. Lena D, Kalfon P, Preiser JC, Ichai C. Glycemic control in the intensive care unit and during the postoperative period. Anesthesiology 2011;114:438-44.
8. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009;37:3001-9.
9. Farrokhi F, Smiley D, Umpierrez GE. Glycemic control in non-diabetic critically ill patients. Best Pract Res Clin Endocrinol Metab 2011;25:813-24.
10. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-8.
11. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007;132: 268-78.
12. Druml W. The "intensive" insulin therapy in artificial feeding. Beneficial effects through normal blood sugar level or insulin therapy? Wien Klin Wochenschr 2006;116: 579-82.
13. Carvalho LSF, Cintra RMR, Moura FA, Martins NVG, Silva JCQ, Coelho OR, Sposito AC; on behalf of the Brasilia Heart Study Group. High plasma HDL-C attenuates stress hyperglycemia during acute phase of myocardial infarction. Atherosclerosis 2011 Oct 4. [Epub ahead of print]
14. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Anesthesiology 2008;109:14-24.
15. Sanjuán R, Núñez J, Blasco ML, Miñana G, Martínez-Maicas H, Carbonell N, Palau P, Bodí V, Sanchis J. Prognostic implications of stress hyperglycemia in acute ST elevation myocardial infarction. Prospective observational study. Rev Esp Cardiol 2011;64:201-7.
16. Cruz-Gonzalez I, Chia S, Raffel OC, Sanchez-Ledesma M, Senatore F, Wackers FJ, Nathan DM, Jang IK. Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Diabetes Res Clin Pract 2010;88:97-102.
17. Goran KP. The consensus is clearly needed for the definition of stress hyperglycaemia in acute myocardial infarction. Eur Heart J 2007;28:2042.
18. Liu Y, Yang Y, Zhu J, Tan H, Liang Y, Li J. Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A Systematic Review and Meta-Analysis. Cardiovasc Diabetology 2011, 10:98.
19. Ertorer ME, Haydardedeoglu FE, Erol T, Anaforoglu I, Binici S, Tutuncu NB, Sezgin A, Demirag NG. Newly diagnosed hyperglycemia and stress hyperglycemia in a coronary intensive care unit. Diabetes Res Clin Pract 2010;90:8-14.
20. Anantharaman R, Heatley M, Weston CF. Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target? Heart 2009;95:697-703.
21. Kotulák T, Ríha H, Haluzík M. Hyperglycemia and its control in the critically ill patient. Cas Lek Cesk 2011;150:20-3.
22. Oshima C, Kaneko T, Tsuruta R, Oda Y, Miyauchi T, Fujita M, Kawamura Y, Kasaoka S, Maekawa T. Increase in plasma glucagon, a factor in hyperglycemia, is related to neurological outcome in postcardiac-arrest patients. Resuscitation 2010;81:187-92.
23. Aronson D, Hammerman H, Suleiman M, Markiewicz W. Usefulness of changes in fasting glucose during hospitalization to predict long-term mortality in patients with acute myocardial infarction. Am J Cardiol 2009; 104:1013-7.
24. Smith FG, Sheehy AM, Vincent JL, Coursin DB. Critical illness-induced dysglycaemia: diabetes and beyond. Crit Care 2010;14:327.
25. Mayer K, Weigand MA, Seeger W. How much insulin does the critical ill need?. Anasthesiol Intensivmed Notfallmed Schmerzther 2011;46:276-82.
26. Ma CX, Cao XY. [An investigation of the relationship of inflammatory response and insulin and its components during stress hyperglycemia in critically ill patients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2011;23:169-72.
27. Jensen CJ, Eberle HC, Nassenstein K, Schlosser T, Farazandeh M, Naber CK, Sabin GV, Bruder O. Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI. Clin Res Cardiol 2011;100:649-59.
28. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005;111:3078-86.
29. Egi M, Finfer S, Bellomo R. Glycemic control in the ICU. Chest 2011;140:212-20.
30. Egi M. Blood glucose control in critically ill perioperative patients. Masui 2011;60:285-92.
31. Bronisz A, Kozinski M, Magielski P, Fabiszak T, Gierach J, Swiatkiewicz I, Sukiennik A, Kubica A, Bronisz M, Grabczewska Z, Sinkiewicz A, Junik R, Kubica J. Value of oral glucose tolerance test in the acute phase of myocardial infarction. Cardiovasc Diabetol 2011;10:21.
32. Lavi S, Kapeliovich M, Gruberg L, Roguin A, Boulos M, Grenadier E, Amikam S, Markiewicz W, Beyar R, Hammerman H. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis. Int J Cardiol 2008;123:117-22.
33. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, Markiewicz W, Aronson D. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005;111:754-60.
34. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GO. Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study. BMC Endocr Disord 2011;11:14.
35. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A. et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 2007;28:88-136.
36. Lankisch M, Füth R, Gülker H, Lapp H, Bufe A, Haastert B, Martin S, Rathmann W. Screening for undiagnosed diabetes in patients with acute myocardial infarction. Clin Res Cardiol 2008;97:753-9.
37. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M. ESC Committee for Practice Guidelines (CPG) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008;29: 2909-45.
38. Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM, Heine RJ. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996;39: 298-305.
39. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
40. Gasior M, Pres D, Stasik-Pres G, Lech P, Gierlotka M, Hawranek M, Wilczek K, Szyguła-Jurkiewicz B, Lekston A, Kalarus Z, Strojek K, Gumprecht J, Poloński L. Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J 2008;15:422-30.
41. Umpierrez GE, Isaacs SD, Bazargan N You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clinl Endocrinol Metab 2002;87:978-982.
42. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocrine Practice 2004;10(Suppl. 2):21-33.
43. Leonidou L, Michalaki M, Leonardou A, Polyzogopoulou E, Fouka K, Gerolymos M, Leonardos P, Psirogiannis A, Kyriazopoulou V, Gogos CA. Stress-induced hyperglycemia in patients with severe sepsis: a compromising factor for survival. Am J Med Sci 2008;336:467-71.
44. Donner TW & Flammer KM. Diabetes management in the hospital. Med Clin North Amer 2008;92:407-425.
45. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Critical Care Med 2003; 31:359-366.
46. Smiley D, Umpierrez GE. Management of hyperglycemia in hospitalized patients. Ann N Y Acad Sci 2010;1212:1-11.
47. Metha SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L; CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005;293:437-46.
48. Quinn TJ, Dawson J, Walters MR. Sugar and Stroke: Cerebrovascular Disease and Blood Glucose Control. Cardiovasc Ther 2010 May 13. [Epub ahead of print]
49. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55:3151-9.
50. Pinto DS, Kirtane AJ, Pride YB, Murphy SA, Sabatine MS, Cannon CP, Gibson CM; CLARITY-TIMI 28 Investigators. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol 2008;101:303-7.
51. Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, Dambrink JH, Bilo HJ, Zijlstra F, van 't Hof AW. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation 2011;124:704-11.
52. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience. Intern Emerg Med 2011;6:41-6.
53. Mackenzie IM, Whitehouse T, Nightingale PG. The metrics of glycemic control in critical care. Intensive Care Med 2011;37:435-43.
54. Kimura K, Sakamoto Y, Iguchi Y, Shibazaki K, Aoki J, Sakai K, Uemura J. Admission hyperglycemia and serial infarct volume after t-PA therapy in patients with and without early recanalization. J Neurol Sci 2011;307:55-9.
55. Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R, Nawaz H. Utility of HbA1c levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 2003;26:1064-8.
56. Koracevic GP, Petrovic S, Damjanovic M, Stanojlovic T. Association of stress hyperglycemia and atrial fibrillation in myocardial infarction. Wien Klin Wochenschr 2008;120:409-13.
57. Stojković A, Koracević G, Perisić Z, Krstić N, Pavlović M, Todorović L, Glasnović J, Burazor I, Apostolović S, Nikolić G, Kostić T, Branković N. [The influence of stress hyperglycemia on the prognosis of patients with acute myocardial infarction and temporary electrical cardiac pacing]. Srp Arh Celok Lek 2010;138:430-5.
58. Ichiki H, Hamasaki S, Nakasaki M, Ishida S, Yoshikawa A, Kataoka T, Ogawa M, Saihara K, Okui H, Orihara K, Shinsato T, Oketani N, Shirasawa T, Ninomiya Y, Kuwahata S, Fujita S, Takumi T, Iriki Y, Yoshino S, Matsushita T, Tei C. Relationship between hyperglycemia and coronary vascular resistance in non-diabetic patients. Int J Cardiol 2010;141:44-8.
59. Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, Hoekstra JB. Hyperglycemia: a prothrombotic factor? J Thromb Haemost 2010;8: 1663-9.
60. Le Guyader A, Davis-Gorman G, Seaver N, CopeIand J, McDonagh P. Stress hyperglycemia impairs platelet inhibition by asprin measured by thromboelastography and VerifyNow (R). Br J Surg 2009;96 (Suppl 5):40.
61. Amabile N, Jacquier A, Shuhab A, Gaudart J, Bartoli JM, Paganelli F, Moulin G. Incidence, predictors and prognostic value of intra myocardial hemorrhage lesions in ST elevation myocardial infarction. Catheter Cardiovasc Interv 2011 Jul 29. [Epub ahead of print]
62. Varo N, Vicent D, Libby P, Nuzzo R, Calle-Pascual AL, Bernal MR, Fernandez-Cruz A, Veves A, Jarolim P, Varo JJ, Goldfine A, Horton E, Schonbeck U. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. Circulation 2003;107:2664-9.
63. Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, Brook GJ, Levy Y. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med 2004;21:39-44.
64. Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, Rifai N, McCabe CH, Gibson CM, Braunwald E. Synergistic relationship between hyperglycemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J 2007;28:806-13.
65. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460-5.
66. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003;107: 690-5.
67. Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schonbeck U. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 2003;108:1049-52.
68. Bower WF, Lee PY, Kong AP, Jiang JY, Underwood MJ, Chan JC, van Hasselt CA. Peri-operative hyperglycemia: a consideration for general surgery? Am J Surg 2010;199:240-8.
69. van der Horst IC, Nijsten MW, Vogelzang M, Zijlstra F. Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction. Cardiovasc Diabetol 2007 6;6:2.
70. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed). 1986;293 (6552):917-22.
71. Valente S, Lazzeri C, Chiostri M, Sori A, Giglioli C, Gensini GF. Prior and new onset anemia in ST-elevation myocardial infarction: a different prognostic role? Intern Emerg Med 2011;6:329-36.
72. Meyfroidt G, Ingels C, Van den Berghe G. Glycemic Control in the ICU. N Engl J Med 2011; 364:1280-1.
73. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999;99:2626-32.
74. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000.
75. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-21.
76. Reed CC, Stewart RM, Sherman M, Myers JG, Corneille MG, Larson N, Gerhardt S, Beadle R, Gamboa C, Dent D, Cohn SM, Pruitt BA Jr. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Col Surg 2007;204:1048-54.
77. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 2009;373 (9663):547-56.
78. Krinsley J, Preiser JC. Intensive insulin therapy to control hyperglycemia in the critically ill: a look back at the evidence shapes the challenges ahead. Crit Care 2010;14:330.
79. Cheung NW. Glucose control during acute myocardial infarction. Intern Med J 2008;38:345-8.
80. Cheung NW, Wong VW, McLean M. What glucose target should we aim for in myocardial infarction? Diabetes Res Clin Pract 2008;80:411-5.
81. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 2011;39:105-11.